Laura Francis - Galvanize Therapeutics®
Skip to the content
MENU
Headshot of Laura Francis, CEO and Board Member, SI-BONE, Inc.

Laura Francis

CEO and Board Member, SI-BONE, Inc.

Laura Francis is the Chief Executive Officer and a Board Member of SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley based high-growth medical device company. She was previously the Chief Financial Officer and Chief Operating Officer of the company. Laura played a pivotal role in bringing the company public in October 2018 and building the operations of the business. Prior to joining SI-BONE, Laura held other executive and leadership roles with public and private life science companies, including Auxogyn, now part of Progyny (Nasdaq: PGNY), Promega Corporation, and Bruker Corporation (Nasdaq: BRKR). Earlier in her career, she was an Engagement Manager with McKinsey & Company and Audit Manager with Coopers & Lybrand, now PricewaterhouseCoopers. Laura was a Board Member of Shockwave Medical, Inc. (Nasdaq: SWAV), where she served as Audit Committee Chair and Compensation Committee Member, prior to its acquisition by Johnson & Johnson. She received a B.B.A. from the University of Wisconsin and a M.B.A. from Stanford University. She is a Certified Public Accountant (inactive) in the State of California.

Back to the team

Important Notice:

Galvanize Therapeutics® is a medical device manufacturer, not a healthcare provider. The information submitted through this form will be used solely to connect you with a physician in your area who uses the Aliya® PEF System. Please do not submit protected health information (PHI) — including diagnosis, treatment history, or medical records — through this form.

The Aliya® PEF System (K212871, K233884, and K253826) is 510(k) cleared in the United States for the surgical ablation of soft tissue. Galvanize Therapeutics® does not promote the off-label use of its products and nothing herein is intended to promote an off-label use of the Aliya PEF System. The Aliya PEF System is a tool for the surgical ablation of soft tissue it is not intended to treat, cure, prevent, nor mitigate any specific disease or condition.

For questions about coverage or eligibility for this procedure, please consult your physician and insurance provider.

I Understand